CD8A and cancer: High Klintrup–Mӓkinen grade and low GMS have both been associated with improved survival, with Klintrup–Mӓkinen being associated with increased levels of CD3, CD8 and FoxP3 and reduced cancer recurrence, propagating a positive association [31, 39].